OR WAIT 15 SECS
Updated employee announcements, business news, awards, and recognition in the industry today.
Jeff Williams, Co-founder, President, and CEO of Clinipace Worldwide, a global CRO that he founded 14 years ago, has elected to move into an expanded advisory role with the company’s Board of Directors. He will be handing over his responsibilities to Jason Monteleone, who will assume the role of CEO.
SynteractHCR, a full-service CRO, announced the appointment of industry veteran John Potthoff to its Board of Directors. Potthoff will bring along his extensive operational, business development, and leadership experience derived through his 25-year career dedicated to clinical development.
Hampton Corley, Chief Business Officer of Clinipace Worldwide has been appointed to the Board of Directors of the American Society of Nephrology’s Kidney Health Initiative.
OmniComm Systems, Inc., announced that Kim Rejndrup has joined the company as the Senior Vice President of Product Development. Mr. Rejndrup brings along 20 years of extensive technical and industry experience.
InClinica, a global clinical CRO, announced that Nathan McCavery has been appointed Director of Business Development. McCavery, with years of prior experience, will be responsible for engaging new clients, developing sales strategies, and expanding market growth in the U.K. and Scandinavia regions.
Comprehend Systems, Inc., provider of Clinical Intelligence Solutions, has named Terry Cunningham CEO.
SCORR Marketing, a global health science marketing and communications firm, has announced the appointment of Joan Chambers as senior strategic advisor. Chambers most recently was COO of CenterWatch.
PPD is sponsoring Walk MS: Austin as part of the PPD Heroes initiative to raise awareness about the life-changing impact of clinical research for patients.
ERT, a global data and technology company, announced it has biopharma companies and CROs using their solutions in more than 10,000 studies worldwide. ERT’s solutions have been used by three million patients and has supported over 550 new drug approvals.
OCT, an Eastern Europe CRO, expands its presence in North America by opening its doors in Boston. With this expansion, they have also brought on new employees such as Anna Yanaeva who has taken on the role as Business Development Director.
Synergy, a CRO has started another RBM project in Russia for a local sponsor in Phase III clinical trial in surgery. Synergy in collaboration with Cyntegrity will provide a cost-effective solution for sponsors and CROs.
Rho, a full-service CRO, announces plans to build a new 159,000-square-foot headquarters in Research Triangle Park, North Carolina. This new building will be 50% larger than their current space.
CluePoints, a provider of RBM and data quality oversight solutions for clinical trials, has further expanded its late phase work in Japan by entering into two new partnerships with global top 20 pharmaceutical companies.
Oracle Health Sciences announced that it has been identified as a Leader in the top quartile in Everest Group’s PEAK Matrix™ Assessment of Life Sciences Clinical Trial Products 2017. Oracle received superior marks in “clinical trials value chain coverage” which included pre-clinical, clinical trials, pharmacovigilance and regulatory affairs.